TGA wants to raise age for OTC cough/cold products
This article was originally published in The Tan Sheet
The Australian Therapeutic Goods Administration recommends raising the minimum age for OTC pediatric cough and cold products to 6 years - the same age 1U.K. regulators recommend and two years older than in the 2U.S. TGA bases the recommendation on an external safety review of data summarized in Australia's 3review of cough and cold medicines in children. It also wants the 4National Drugs and Poisons Schedule Committee to make cough and cold products for 6- to 12-year-olds available only from a pharmacist, and wants manufacturers to package all cough and cold products in child-resistant containers by July 2010
You may also be interested in...
Manufacturers of pediatric cough/cold medicines sold in the U.K. have until March 2010 before the products must be sold behind the pharmacy counter, one of several measures to improve safe use
FDA advisory committees recommend not only standardizing language on OTC pediatric cough/cold product labels, but also dosing devices for the products
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.